OSIA
PFE icon

O'Shares Investment Advisers’s Pfizer PFE Stock Holding History

O'Shares Investment Advisers’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-593,080
Closed -$30.7M – 193
2022
Q1 		$30.7M Buy
593,080
+33,137
+6% +$1.72M 2.43% 6
2021
Q4 		$33.1M Buy
559,943
+40,672
+8% +$2.02M 2.36% 6
2021
Q3 		$22.3M Sell
519,271
-18,226
-3% -$807K 1.64% 9
2021
Q2 		$21M Buy
537,497
+14,540
+3% +$565K 1.48% 12
2021
Q1 		$18.9M Sell
522,957
-1,043
-0.2% -$37K 1.41% 12
2020
Q4 		$19.3M Buy
524,000
+22,713
+5% +$833K 1.47% 13
2020
Q3 		$17.5M Buy
501,287
+230,306
+85% +$8.07M 1.82% 9
2020
Q2 		$8.41M Sell
270,981
-210,027
-44% -$7.14M 1.06% 21
2020
Q1 		$14.9M Sell
481,008
-371
-0.1% -$12.6K 2.66% 6
2019
Q4 		$17.9M Buy
481,379
+27,864
+6% +$992K 2.46% 6
2019
Q3 		$15.5M Buy
453,515
+136,986
+43% +$4.98M 2.33% 8
2019
Q2 		$13M Buy
316,529
+18,492
+6% +$734K 2.08% 8
2019
Q1 		$12M Buy
298,037
+8,701
+3% +$348K 2.04% 8
2018
Q4 		$12M Buy
+289,336
New +$12M 2.29% 6

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

O'Shares Investment Advisers's PFE Position: Q2 2022 in Review

O'Shares Investment Advisers sold out of Pfizer (PFE) in Q2 2022, closing a stake of 593,080 shares — an estimated $30.7M sold.

O'Shares Investment Advisers first reported a position in PFE in Q4 2018 and held it in 14 quarters. The position peaked at $33.1M in Q4 2021. 3,157 funds tracked by Wall St. Rank hold PFE as of Q2 2022.

  • O'Shares Investment Advisers reported no remaining Pfizer position as of Q2 2022 after selling out during the quarter.
  • O'Shares Investment Advisers sold 593,080 Pfizer shares in Q2 2022, an estimated $30.7M.
  • O'Shares Investment Advisers first reported a position in Pfizer in Q4 2018 and held it in 14 quarters.
  • O'Shares Investment Advisers's Pfizer position peaked at $33.1M in Q4 2021.
  • 3,157 funds tracked by Wall St. Rank held Pfizer as of Q2 2022.

Based on O'Shares Investment Advisers's 13F filing for Q2 2022.